Human Plus Fund successful first close achieved
The Netherlands’ Human Plus Fund has successfully achieved the first close of its biomedical innovation fund. Initial commitments are earmarked for the two first investments which were selected together with the Netherlands Cancer Institute – Antoni van Leeuwenhoek hospital, NKI-AVL. Two spin-off companies have now been established as a result
April 6, 2021
